Diabetes control through subcutaneous insulin infusion (CSU) is currently the therapeutic option that most closely mimics physiologic insulin secretion and provides for glycemia levels close to normál even where standard injection insulin therapy fails. Following CSU installation, the mean daily dose of insulin usually decreases and diabetes control improves (HBAlc falls). Most patients háve the CSU installed because of poor diabetes control. The most frequent indications are the "dawn phenomenon", severe hypoglycemia, and progression of diabetic complications.

        Key words: Diabetes mellitus, continuous subcutaneous insulin infusion (CSU), insulin pump